Table 2:

Rates of hemorrhage by length of time since starting warfarin therapy

CharacteristicHemorrhages during 5-yr follow-up, no. (%)*Rate of hemorrhage, % per person-year (95% CI)
First 30 dRemainder of 5-yr follow-upOverall
Overall, no.10 84011.8 (11.1–12.4)3.4 (3.4–3.5)3.8 (3.8–3.9)
CHADS2 score
 0382 (3.5)7.2 (5.5–9.5)1.6 (1.4–1.7)1.8 (1.6–2.0)
 11 845 (17.0)7.3 (6.3–8.4)2.3 (2.2–2.4)2.5 (2.4–2.6)
 2–37 053 (65.1)13.3 (12.5–14.3)3.8 (3.7–3.9)4.3 (4.2–4.4)
 4–61 560 (14.4)16.7 (14.3–19.4)6.0 (5.7–6.3)6.7 (6.3–7.0)
Type of hemorrhage
 Intracranial549 (5.1)0.4 (0.4–0.5)0.2 (0.2–0.2)0.2 (0.2–0.2)
 Upper gastrointestinal2 829 (26.1)4.0 (3.8–4.2)0.9 (0.8–0.9)1.0 (1.0–1.0)
 Lower gastrointestinal3 956 (36.5)4.6 (4.4–4.9)1.2 (1.2–1.3)1.4 (1.4–1.4)
 Other4 190 (38.7)4.7 (4.5–5.0)1.3 (1.3–1.3)1.5 (1.5–1.5)
Age ≤ 75 yr, no.36849.2 (8.4–10.2)2.6 (2.5–2.7)2.9 (2.8–3.0)
CHADS2 score
 0382 (10.4)7.2 (5.5–9.5)1.6 (1.4–1.7)1.8 (1.6–2.0)
 11 204 (32.7)6.8 (5.7–8.1)2.0 (1.9–2.2)2.3 (2.1–2.4)
 2–31 881 (51.1)12.1 (10.6–13.9)3.4 (3.3–3.6)3.9 (3.7–4.0)
 4–6217 (5.9)13.1 (8.2–20.7)5.5 (4.8–6.4)6.0 (5.3–6.9)
Type of hemorrhage
 Intracranial194 (5.3)0.4 (0.3–0.4)0.1 (0.1–0.1)0.2 (0.1–0.2)
 Upper gastrointestinal1 055 (28.6)3.9 (3.5–4.3)0.7 (0.7–0.7)0.8 (0.8–0.9)
 Lower gastrointestinal1 268 (34.4)3.5 (3.2–3.9)0.9 (0.9–0.9)1.0 (1.0–1.0)
 Other1 406 (38.2)3.3 (3.0–3.7)1.0 (1.0–1.0)1.1 (1.1–1.1)
Age > 75 yr, no.7 15613.7 (12.7–14.6)4.1 (4.0–4.2)4.6 (4.5–4.7)
CHADS2 score
 00 (0.0)
 1641 (9.0)8.5 (6.6–10.9)2.8 (2.6–3.1)3.1 (2.9–3.4)
 2–35 172 (72.3)13.8 (12.8–15.0)4.0 (3.9–4.1)4.5 (4.4–4.6)
 4–61 343 (18.8)17.3 (14.6–20.3)6.1 (5.7–6.4)6.8 (6.4–7.1)
Type of hemorrhage
 Intracranial355 (5.0)0.5 (0.4–0.5)0.2 (0.2–0.2)0.2 (0.2–0.2)
 Upper gastrointestinal1 774 (24.8)4.1 (3.8–4.3)1.0 (1.0–1.0)1.1 (1.1–1.2)
 Lower gastrointestinal2 688 (37.6)5.5 (5.1–5.9)1.5 (1.5–1.6)1.7 (1.7–1.8)
 Other2 784 (38.9)5.7 (5.3–6.1)1.6 (1.5–1.6)1.8 (1.8–1.8)
  • Note: CI = confidence interval.

  • * Unless otherwise indicated